{
  "trial_id": "NCT02942264",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "prior disease relapses",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "pathologic diagnosis of anaplastic astrocytoma",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "histologically proven or imaging suggestive of recurrent disease",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "ability to understand and willingness to sign a written informed consent document",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "greater than or equal to 18 years old",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "no more than two prior disease relapses",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "tumor tissue available for review to confirm histological diagnosis",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Karnofsky > 60 percent",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "receiving any other investigational agents",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "prior bevacizumab use for tumor treatment",
      "label": "met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and is experiencing progressive lower extremity weakness and urinary retention.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT02942264",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test"
  }
}